TSX-V:EVMT - CA30053H1055 - Common Stock
The current stock price of EVMT.CA is 0.005 CAD. In the past year, price decreased by -97.37%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRN.CA | PROFOUND MEDICAL CORP | N/A | 185.11M | ||
MIR.CA | MEDMIRA INC | N/A | 60.66M | ||
TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 52.03M | ||
CNVI.CA | CONAVI MEDICAL CORP | N/A | 33.39M | ||
PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 25.54M | ||
NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 21.24M | ||
MDX.CA | MEDX HEALTH CORP | N/A | 21.13M | ||
ASG.CA | AURORA SPINE CORP | N/A | 20.85M | ||
VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 19.20M | ||
THRM.CA | THERMA BRIGHT INC | N/A | 3.69M |
Evome Medical Technologies, Inc. engages in the provision of financial and consultancy services to the mental health and addiction industry. The company is headquartered in Shirley, New York and currently employs 195 full-time employees. The company went IPO on 2014-03-28. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. The company offers concussion, fall screening and balance assessment and training programs.
EVOME MEDICAL TECHNOLOGIES I
49 Natcon Drive
Shirley NEW YORK US
Employees: 195
Phone: 18007606826
The current stock price of EVMT.CA is 0.005 CAD.
The exchange symbol of EVOME MEDICAL TECHNOLOGIES I is EVMT and it is listed on the TSX Venture Exchange exchange.
EVMT.CA stock is listed on the TSX Venture Exchange exchange.
EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) has a market capitalization of 300.85K CAD. This makes EVMT.CA a Nano Cap stock.
EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) currently has 195 employees.
The Revenue of EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) is expected to decline by -0.65% in the next year. Check the estimates tab for more information on the EVMT.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EVMT.CA does not pay a dividend.
EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) will report earnings on 2025-08-11.
EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.29).
ChartMill assigns a fundamental rating of 2 / 10 to EVMT.CA. EVMT.CA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months EVMT.CA reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS increased by 4.5% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -66.99% | ||
ROE | N/A | ||
Debt/Equity | N/A |
For the next year, analysts expect an EPS growth of -400% and a revenue growth -0.65% for EVMT.CA